Select for export Perceived harm, motivations for use and subjective experiences of recreational psychedelic ‘magic’ mushroom use Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881120936508 PubMed 32674668 Copy citation Copy BibTeX Journal of Psychopharmacology 2020-07-16 Carl Roberts, Isaac Osborne-Miller, Jon C. Cole, Suzanne H. Gage, Paul Christiansen OpenAlex Published psilocybin AddictionChronic PainObservational Study Observational Study More
Select for export Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan No abstract availability was recorded for this entry. Details DOI 10.1007/s00213-020-05533-9 PubMed 32500212 Copy citation Copy BibTeX Psychopharmacology 2020-06-04 Theresa M. Carbonaro, Matthew W. Johnson, Roland R. Griffiths OpenAlex Published psilocybin Chronic PainPharmacology Other More
Select for export Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41386-020-0718-8 PubMed 32446245 Copy citation Copy BibTeX Neuropsychopharmacology 2020-05-22 Natasha L. Mason, Kim P. C. Kuypers, Felix Müller, Johannes T. Reckweg, Desmond H. Y. Tse, Stefan W. Toennes OpenAlex Published psilocybin DepressionBrain ImagingMechanism of Action Clinical Trial More
Select for export Data justify further research on potential of psychedelics in treating psychiatric disorders Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/pu.30581 Copy citation Copy BibTeX The Brown University Psychopharmacology Update 2020-05-05 Authors unavailable OpenAlex Published psilocybin PharmacologyReceptor PharmacologyReview Article Review Article More
Select for export Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse No abstract availability was recorded for this entry. Details DOI 10.1038/s41386-020-0694-z PubMed 32369828 Copy citation Copy BibTeX Neuropsychopharmacology 2020-05-04 Marcus W. Meinhardt, Cansu Güngör, Ivan Skorodumov, Lea J. Mertens, Rainer Spanagel OpenAlex Published psilocybin AddictionPharmacologyReceptor Pharmacology Clinical Trial More
Select for export Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/cpdd.796 PubMed 32250059 Copy citation Copy BibTeX Clinical Pharmacology in Drug Development 2020-04-05 Elyes Dahmane, Paul R. Hutson, Jogarao Gobburu OpenAlex Published psilocybinpsilocin DepressionPharmacologyReceptor Pharmacology Clinical Trial More
Select for export A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2020.02.001 PubMed 32146028 Copy citation Copy BibTeX European Neuropsychopharmacology 2020-03-03 M. Madsen, Patrick M. Fisher, Dea Siggaard Stenbæk, Sara Kristiansen, Daniel Burmester, Szabolcs Lehel OpenAlex Published psilocybin Receptor Pharmacology Other More
Select for export Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881120908004 PubMed 32108529 Copy citation Copy BibTeX Journal of Psychopharmacology 2020-02-27 Daniel Rosenbaum, Cory R. Weissman, Thomas Anderson, Rotem Petranker, Lê-Anh Dinh-Williams, Katrina Hui OpenAlex Published psilocybin AnxietyAddictionMicrodosing Randomized Controlled Trial More
Select for export Self-reported negative outcomes of psilocybin users: A quantitative textual analysis Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0229067 PubMed 32084160 Copy citation Copy BibTeX PLoS ONE 2020-02-20 Bheatrix Bienemann, Nina Stamato Ruschel, Maria Luiza Pesse Campos, Marco Aurélio Negreiros, Daniel C. Mograbi OpenAlex Published psilocybin DepressionAddictionTreatment-Resistant Depression Other More
Select for export Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2019.00896 PubMed 32116806 Copy citation Copy BibTeX Frontiers in Psychiatry 2020-02-10 James Sexton, Charles D. Nichols, Peter S. Hendricks OpenAlex Published psilocybin PharmacologyObservational StudySafety Observational Study More
Select for export Effects of psilocin on the striatal monoamine contents in mice and rats No abstract availability was recorded for this entry. Details Copy citation Copy BibTeX The Pharmaceutical Society of Japan 2020-01-31 Maho Hirasawa OpenAlex Published psilocin Receptor PharmacologyAnimal Study Animal Study More
Select for export P.324 Acute effects of psilocybin on glutamate concentration levels, functional connectivity and subjective state No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2019.12.087 Copy citation Copy BibTeX European Neuropsychopharmacology 2020-01-27 Natasha L. Mason, Kim P. C. Kuypers, Johannes T. Reckweg, Desmond H. Y. Tse, Felix Müller, Stefan W. Toennes OpenAlex Published psilocybin General Other More
Select for export Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2019.00955 PubMed 32038317 Copy citation Copy BibTeX Frontiers in Psychiatry 2020-01-21 Albert Garcia-Romeu, Alan K. Davis, Earth Erowid, Fire Erowid, Roland R. Griffiths, Matthew W. Johnson OpenAlex Published psilocybin AddictionChronic PainReceptor Pharmacology Observational Study More
Select for export Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881119895520 PubMed 31941394 Copy citation Copy BibTeX Journal of Psychopharmacology 2020-01-15 Lea J. Mertens, Matthew B. Wall, Leor Roseman, Lysia Demetriou, David Nutt, Robin Carhart-Harris OpenAlex Published psilocybin DepressionChronic PainBrain Imaging Other More
Select for export Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881119897615 PubMed 31916890 Copy citation Copy BibTeX Journal of Psychopharmacology 2020-01-08 Gabrielle Agin-Liebes, Tara C. Malone, Matthew M. Yalch, Sarah E. Mennenga, Katherine Ponte, Jeffrey Guss OpenAlex Published psilocybin DepressionAnxietyEnd-of-Life Distress Randomized Controlled Trial More
Select for export A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamines Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/hup.2719 PubMed 31909513 Copy citation Copy BibTeX Human Psychopharmacology Clinical and Experimental 2019-12-31 Joseph J. Palamar, Patricia Acosta OpenAlex Published psilocybin PharmacologyToxicity Qualitative Study More
Select for export Psychedelic Microdosing: A Subreddit Analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2019.1683260 PubMed 31648596 Copy citation Copy BibTeX Journal of psychoactive drugs 2019-12-31 Lea T, Amada N, Jungaberle H PubMed Published psilocybin DepressionAnxietyMicrodosing Other More
Select for export P.228 The polypharmacological profile of psilocybin and potential behavioural effects of very low doses No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2019.09.271 Copy citation Copy BibTeX European Neuropsychopharmacology 2019-11-30 K. Kiilerich, Nikolaj Speth, J. Lorenz, Agata Casado-Sainz, Vladimir Shalgunov, Denise Lange OpenAlex Published psilocybin PharmacologyOxidative Stress Other More
Select for export P.188 Long-term effects of psilocybin on cerebral serotonin 2A receptor levels and personality No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2019.09.232 Copy citation Copy BibTeX European Neuropsychopharmacology 2019-11-30 Mie Madsen, P.M. Fisher, D.S. Stenbæk, S. Kristiansen, D. Burmester, S. Lehel OpenAlex Published psilocybin Receptor PharmacologyPersonality Change Other More
Select for export P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2019.09.593 Copy citation Copy BibTeX European Neuropsychopharmacology 2019-11-30 Laura Mertens, M.B. Wall, L. Roseman, L. Demetriou, D.J. Nutt, R.L. Carhart-Harris OpenAlex Published psilocybin DepressionMechanism of ActionEmotional Processing Clinical Trial More
